These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7517119)

  • 1. Interferon and the incorporation of 5-fluorouracil into RNA of normal tissues and a secondary liver carcinoma in rat.
    Roos G; Stenram U
    Anticancer Res; 1994; 14(2A):379-82. PubMed ID: 7517119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of 5-fluorouracil into RNA of normal tissues and an adenocarcinoma in protein-deprived rats.
    el Hag IA; Jakobsson B; Erichsen C; Christensson PI; Jönsson PE; Stenram U
    In Vivo; 1987; 1(4):215-20. PubMed ID: 2485132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of 5-fluorouracil and 5-fluorouridine toxicity by membrane transport inhibitors in normal tissues of rats with liver adenocarcinoma.
    Jakobsson B; el Hag IA; Erichsen C; Christensson PI; Jönsson PE; Stenram U
    Anticancer Res; 1989; 9(2):285-90. PubMed ID: 2751255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of 5-fluorouracil toxicity by uridine, deoxyuridine, orotate and dipyridamole in normal tissues of rats with liver adenocarcinoma.
    el Hag IA; Jakobsson B; Christensson PI; Erichsen C; Jönsson PE; Stenram U
    In Vivo; 1987; 1(5):309-12. PubMed ID: 2485133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA labelling with 3H-orotic acid and 3H-fluorouracil of rat liver tumour following transient hepatic arterial ischaemia.
    Mack P; Tranberg KG; Strenram U; Jeppsson B; Widlus D; Bengmark S
    Eur J Surg Oncol; 1988 Dec; 14(6):669-75. PubMed ID: 3192004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporation of 5-fluorouracil into rat liver tumor and normal tissues and the liver nucleotide profile after administration by the hepatic artery during portal venous branch ligation.
    Jakobsson B; Roos G; el Hag IA; Jönsson PE; Stenram U
    Res Exp Med (Berl); 1992; 192(1):13-21. PubMed ID: 1570410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incorporation of 5-fluorouracil into rat liver tumor and normal tissues after administration by the hepatic artery during temporary portal vein clamping.
    el Hag IA; Jakobsson B; Jönsson PE; Stenram U
    Res Exp Med (Berl); 1990; 190(3):183-92. PubMed ID: 1695018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic effect of polyinosinic-polycytidylic acid on the cell lethality produced by 5-fluorouracil in human colon carcinoma cells in vitro.
    Iigo M; Glazer RI
    Cancer Res; 1985 May; 45(5):1953-7. PubMed ID: 2580613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on DNA and RNA after the administration of two different schedules of 5-fluorouracil in colorectal cancer patients.
    Hoshino S; Yamashita Y; Maekawa T; Shirakusa T
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):648-52. PubMed ID: 15959779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradable starch microspheres in cytostatic treatment of a liver carcinoma; experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubicin and RSU-1069.
    Roos G; Christensson PI; el Hag IA; Jakobsson B; Teder H; Stenram U
    Anticancer Res; 1993; 13(3):635-41. PubMed ID: 8317891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential recovery of intestine, bone marrow, and thymus of rats with solid tumors following 5-fluorouracil administration.
    Hopkins HA; Kovacs CJ; Looney WB; Wakefield JA
    Cancer Biochem Biophys; 1976; 1(6):303-12. PubMed ID: 189899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil incorporation into RNA of a rat liver adenocarcinoma after hepatic artery injection together with degradable starch microspheres.
    Teder H; Erichsen C; Christensson PI; Jönsson PE; Stenram U
    Cancer Drug Deliv; 1987; 4(3):169-76. PubMed ID: 2453264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hepatic artery ligation on the incorporation of 3H-orotic acid into an adenocarcinoma transplanted to rat liver.
    Erichsen C; Christensson PI; Jönsson PE; Stenram U
    Eur J Surg Oncol; 1986 Jun; 12(2):181-6. PubMed ID: 2423375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
    Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
    Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and distribution studies with radiolabeled 5-fluorouracil.
    Young D; Vine E; Ghanbarpour A; Shani J; Siemsen JK; Wolf W
    Nuklearmedizin; 1982 Feb; 21(1):1-7. PubMed ID: 6281741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of 5-fluorouracil-induced toxicity in mice with interferon or with the interferon inducer, polyinosinic-polycytidylic acid.
    Stolfi RL; Martin DS; Sawyer RC; Spiegelman S
    Cancer Res; 1983 Feb; 43(2):561-6. PubMed ID: 6184150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The target cell determinants of the antitumor actions of 5-FU: does FU incorporation into RNA play a role?
    Mandel HG
    Cancer Treat Rep; 1981; 65 Suppl 3():63-71. PubMed ID: 6179616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the mechanism of cytotoxicity of 5-fluorouracil--through impairment of metabolism].
    Ikenaka K; Tanaka H; Kawai K; Shirasaka T; Fujii S
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):227-31. PubMed ID: 6349531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.